Pharma & HealthcareHold

PGIM India Healthcare

PGIM India · Direct–Growth · rank #9 of 18 by Smart Score

Compare Source ↗

Trailing returns

vs Nifty 500 (index-fund proxy)

1 Year

16.2%

+15.7% vs index

3 Years

—

5 Years

—

Since launch

11.5%

Year-by-year performance

last entry = YTD

2025

-1.0%-8.7% vs index

2026

+18.6%+20.3% vs index

Why this score

PGIM India Healthcare scores 51/100 — #9 of 18 Pharma & Healthcare fund (Hold). It stands out for volatility and expense ratio — beating 91% of peers on volatility. The main drag is its sharpe ratio (better than only 15% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

Sharpe ratio0.38 · 15th percentile in category

Volatility13.38 · 91st percentile in category

Fund size103.24 Cr · 8th percentile in category

Expense ratio0.86% · 86th percentile in category

Sortino ratio0.51 · 16th percentile in category

Alpha8.01 · 74th percentile in category

Other Pharma & Healthcare funds

HDFC Pharma And Healthcare

3Y —

SBI Healthcare Opportunities

3Y 24.7%

ICICI Pru Pharma Healthcare And Diagnostics PHD

3Y 25.6%

UTI Healthcare

3Y 26.4%